IMUX Immunic | $1.31
+12.3% | 3/25/2025 | Initiated by | William Blair | Analyst Myles Minter | Outperform | | Low | View details for William Blair rating of Immunic (NASDAQ:IMUX) on 3/25/2025 |
AZEK AZEK | $48.72
+0.3% | 3/24/2025 | Reiterated by | William Blair | Analyst Ryan Merkel | Outperform -> Market Perform | | High | View details for William Blair rating of AZEK (NYSE:AZEK) on 3/24/2025 |
TRU TransUnion | $88.01
+0.3% | 3/24/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of TransUnion (NYSE:TRU) on 3/24/2025 |
ALNY Alnylam Pharmaceuticals | $289.39
-0.5% | 3/21/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/21/2025 |
ANRO Alto Neuroscience | $2.61
-1.5% | 3/21/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Alto Neuroscience (NYSE:ANRO) on 3/21/2025 |
SKYE Skye Bioscience | $2.11
-10.3% | 3/21/2025 | Reiterated by | William Blair | Analyst A. Hsieh | Outperform | | High | View details for William Blair rating of Skye Bioscience (NASDAQ:SKYE) on 3/21/2025 |
SKYE Skye Bioscience | $2.11
-22.7% | 3/21/2025 | Reiterated by | William Blair | Analyst A. Hsieh | Outperform | | High | View details for William Blair rating of Skye Bioscience (NASDAQ:SKYE) on 3/21/2025 |
TERN Terns Pharmaceuticals | $3.35
-4.7% | 3/21/2025 | Reiterated by | William Blair | Analyst A. Hsieh | Market Perform | | High | View details for William Blair rating of Terns Pharmaceuticals (NASDAQ:TERN) on 3/21/2025 |
VMI Valmont Industries | $300.06
+0.4% | 3/21/2025 | Downgraded by | William Blair | Analyst Brian Drab | Outperform -> Market Perform | | High | View details for William Blair rating of Valmont Industries (NYSE:VMI) on 3/21/2025 |
BECN Beacon Roofing Supply | $123.81
0.0% | 3/20/2025 | Reiterated by | William Blair | Analyst Ryan Merkel | Outperform -> Market Perform | | Low | View details for William Blair rating of Beacon Roofing Supply (NASDAQ:BECN) on 3/20/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
NVDA NVIDIA | $119.53
-1.5% | 3/20/2025 | Reiterated by | William Blair | Analyst S. Naji | Outperform | | Low | View details for William Blair rating of NVIDIA (NASDAQ:NVDA) on 3/20/2025 |
PBPB Potbelly | $9.67
-1.2% | 3/20/2025 | Reiterated by | William Blair | - | Market Perform | | Medium | View details for William Blair rating of Potbelly (NASDAQ:PBPB) on 3/20/2025 |
INCY Incyte | $62.86
+0.1% | 3/18/2025 | Downgraded by | William Blair | Analyst Y Katherine Xu | Outperform -> Market Perform | | High | View details for William Blair rating of Incyte (NASDAQ:INCY) on 3/18/2025 |
CFLT Confluent | $27.18
-0.5% | 3/17/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Confluent (NASDAQ:CFLT) on 3/17/2025 |
DOCU DocuSign | $90.31
+1.5% | 3/17/2025 | Upgraded by | William Blair | Analyst Bhavan Suri | Market Perform -> Outperform | | High | View details for William Blair rating of DocuSign (NASDAQ:DOCU) on 3/17/2025 |
BFLY Butterfly Network | $2.72
-3.4% | 3/17/2025 | Initiated by | William Blair | Analyst Andrew Brackmann | Outperform | | Medium | View details for William Blair rating of Butterfly Network (NYSE:BFLY) on 3/17/2025 |
ALT Altimmune | $5.92
-2.2% | 3/14/2025 | Reiterated by | William Blair | Analyst A. Hsieh | Market Perform | | Low | View details for William Blair rating of Altimmune (NASDAQ:ALT) on 3/14/2025 |
NABL N-able | $7.56
+0.4% | 3/14/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of N-able (NYSE:NABL) on 3/14/2025 |
NKTR Nektar Therapeutics | $0.82
-4.4% | 3/13/2025 | Reiterated by | William Blair | - | Market Perform | | Medium | View details for William Blair rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/13/2025 |
FIVN Five9 | $31.36
+1.6% | 3/13/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Five9 (NASDAQ:FIVN) on 3/13/2025 |
UDMY Udemy | $8.80
-0.2% | 3/12/2025 | Downgraded by | William Blair | Analyst Stephen Sheldon | Outperform -> Market Perform | | High | View details for William Blair rating of Udemy (NASDAQ:UDMY) on 3/12/2025 |
TLX Telix Pharmaceuticals Limited American Depositary Shares | $18.31
+0.4% | 3/12/2025 | Reiterated by | William Blair | Analyst A. Hsieh | Outperform | | Low | View details for William Blair rating of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) on 3/12/2025 |
XGN Exagen | $3.96
-2.2% | 3/12/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Exagen (NASDAQ:XGN) on 3/12/2025 |
MGIC Magic Software Enterprises | $13.36
+1.0% | 3/12/2025 | Downgraded by | William Blair | Analyst Maggie Nolan | Outperform -> Market Perform | | High | View details for William Blair rating of Magic Software Enterprises (NASDAQ:MGIC) on 3/12/2025 |
SXI Standex International | $169.41
+0.1% | 3/11/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Standex International (NYSE:SXI) on 3/11/2025 |
GMAB Genmab A/S | $19.43
+0.7% | 3/11/2025 | Upgraded by | William Blair | Analyst Matt Phipps | Market Perform -> Outperform | | High | View details for William Blair rating of Genmab A/S (NASDAQ:GMAB) on 3/11/2025 |
ZLDPF Zealand Pharma A/S | $83.52
| 3/7/2025 | Upgraded by | William Blair | Analyst A. Hsieh | Hold -> Strong-Buy | | High | View details for William Blair rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 3/7/2025 |
PLTR Palantir Technologies | $96.27
-0.5% | 3/5/2025 | Target Set by | William Blair | Analyst L. Dipalma | | $84.00 | N/A | View details for William Blair rating of Palantir Technologies (NASDAQ:PLTR) on 3/5/2025 |
CCL Carnival Co. & | $21.54
+0.5% | 3/10/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Carnival Co. & (NYSE:CCL) on 3/10/2025 |
HURN Huron Consulting Group | $144.79
+1.3% | 3/10/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Huron Consulting Group (NASDAQ:HURN) on 3/10/2025 |
TENX Tenax Therapeutics | $6.35
+2.5% | 3/10/2025 | Reiterated by | William Blair | Analyst M. Phipps | Outperform | | Low | View details for William Blair rating of Tenax Therapeutics (NASDAQ:TENX) on 3/10/2025 |
KRMN Karman | $37.04
-1.3% | 3/10/2025 | Initiated by | William Blair | Analyst Louie DiPalma | Outperform | | High | View details for William Blair rating of Karman (NYSE:KRMN) on 3/10/2025 |
NMRA Neumora Therapeutics | $1.17
-2.9% | 3/10/2025 | Downgraded by | William Blair | Analyst M. Minter | Outperform -> Market Perform | | High | View details for William Blair rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/10/2025 |
GWW W.W. Grainger | $992.90
+0.1% | 3/10/2025 | Upgraded by | William Blair | Analyst Ryan Merkel | Market Perform -> Outperform | | Low | View details for William Blair rating of W.W. Grainger (NYSE:GWW) on 3/10/2025 |
FAST Fastenal | $77.14
+0.3% | 3/10/2025 | Upgraded by | William Blair | Analyst Ryan Merkel | Market Perform -> Outperform | | Low | View details for William Blair rating of Fastenal (NASDAQ:FAST) on 3/10/2025 |
NCMI National CineMedia | $5.79
-0.8% | 3/7/2025 | Reiterated by | William Blair | - | Neutral | $7.50 | High | View details for William Blair rating of National CineMedia (NASDAQ:NCMI) on 3/7/2025 |
PBPB Potbelly | $9.67
-1.2% | 3/7/2025 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Potbelly (NASDAQ:PBPB) on 3/7/2025 |
MLNK MeridianLink | $19.46
-0.2% | 3/7/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of MeridianLink (NYSE:MLNK) on 3/7/2025 |
AVIR Atea Pharmaceuticals | $3.21
+0.3% | 3/7/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Atea Pharmaceuticals (NASDAQ:AVIR) on 3/7/2025 |
ELEV Elevation Oncology | $0.28
-4.2% | 3/7/2025 | Reiterated by | William Blair | Analyst A. Hsieh | Outperform | $5.00 | Medium | View details for William Blair rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2025 |
Most gold “analysts” aren’t really gold analysts… [watch out] (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.  Go here to learn about my Top Four picks for the coming bull mania. |
STVN Stevanato Group | €21.28
-4.8% | 3/7/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Stevanato Group (NYSE:STVN) on 3/7/2025 |
AVGO Broadcom | $190.30
-0.5% | 3/7/2025 | Reiterated by | William Blair | Analyst S. Naji | Outperform | | High | View details for William Blair rating of Broadcom (NASDAQ:AVGO) on 3/7/2025 |
CFLT Confluent | $27.18
-0.5% | 3/7/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Confluent (NASDAQ:CFLT) on 3/7/2025 |
NOW ServiceNow | $865.43
+1.8% | 3/7/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of ServiceNow (NYSE:NOW) on 3/7/2025 |
APEI American Public Education | $22.90
-0.6% | 3/7/2025 | Upgraded by | William Blair | Analyst Stephen Sheldon | Market Perform -> Outperform | | High | View details for William Blair rating of American Public Education (NASDAQ:APEI) on 3/7/2025 |
AVAV AeroVironment | $129.60
+0.7% | 3/5/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of AeroVironment (NASDAQ:AVAV) on 3/5/2025 |
PLTR Palantir Technologies | $96.27
-0.5% | 3/5/2025 | Upgraded by | William Blair | Analyst Louie DiPalma | Underperform -> Market Perform | | High | View details for William Blair rating of Palantir Technologies (NASDAQ:PLTR) on 3/5/2025 |
BDSX Biodesix | $0.81
-2.8% | 3/4/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Biodesix (NASDAQ:BDSX) on 3/4/2025 |
AVPT AvePoint | $15.51
+0.5% | 3/4/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of AvePoint (NASDAQ:AVPT) on 3/4/2025 |
FTRE Fortrea | $8.98
-4.5% | 3/4/2025 | Reiterated by | William Blair | Analyst Max Smock | Market Perform -> Market Perform | | High | View details for William Blair rating of Fortrea (NASDAQ:FTRE) on 3/4/2025 |
SPRY ARS Pharmaceuticals | $12.84
-0.4% | 3/3/2025 | Reiterated by | William Blair | Analyst L. Hanbury-Brown | Outperform | | Medium | View details for William Blair rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/3/2025 |
ZLDPF Zealand Pharma A/S | $83.52
| 2/27/2025 | Upgraded by | William Blair | Analyst A. Hsieh | Hold | | High | View details for William Blair rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 2/27/2025 |
CSGP CoStar Group | $79.85
-0.4% | 2/28/2025 | Initiated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of CoStar Group (NASDAQ:CSGP) on 2/28/2025 |
CIGI Colliers International Group | $126.15
-0.6% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Colliers International Group (NASDAQ:CIGI) on 2/28/2025 |
JAMF Jamf | $13.45
+1.3% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Jamf (NASDAQ:JAMF) on 2/28/2025 |
VITL Vital Farms | $31.80
+1.4% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Vital Farms (NASDAQ:VITL) on 2/28/2025 |
CODI Compass Diversified | $19.31
-1.4% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Compass Diversified (NYSE:CODI) on 2/28/2025 |
FA First Advantage | $14.00
| 2/28/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of First Advantage (NYSE:FA) on 2/28/2025 |
ALHC Alignment Healthcare | $17.64
+1.0% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Alignment Healthcare (NASDAQ:ALHC) on 2/28/2025 |
DNLI Denali Therapeutics | $14.52
-1.6% | 2/28/2025 | Reiterated by | William Blair | Analyst S. Schram | Outperform | | High | View details for William Blair rating of Denali Therapeutics (NASDAQ:DNLI) on 2/28/2025 |
LFST LifeStance Health Group | $6.85
+1.4% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of LifeStance Health Group (NASDAQ:LFST) on 2/28/2025 |
MRUS Merus | $47.96
-1.7% | 2/28/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Merus (NASDAQ:MRUS) on 2/28/2025 |
XENE Xenon Pharmaceuticals | $35.67
-2.2% | 2/28/2025 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | Medium | View details for William Blair rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 2/28/2025 |
ARGX argenx | $610.43
+0.4% | 2/28/2025 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | Low | View details for William Blair rating of argenx (NASDAQ:ARGX) on 2/28/2025 |
KZR Kezar Life Sciences | $5.64
-8.4% | 2/28/2025 | Reiterated by | William Blair | Analyst M. Phipps | Market Perform -> Outperform | | High | View details for William Blair rating of Kezar Life Sciences (NASDAQ:KZR) on 2/28/2025 |
TERN Terns Pharmaceuticals | $3.35
-4.7% | 2/28/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Market Perform | | Low | View details for William Blair rating of Terns Pharmaceuticals (NASDAQ:TERN) on 2/28/2025 |
GPCR Structure Therapeutics | $20.73
-1.5% | 2/28/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Outperform | | High | View details for William Blair rating of Structure Therapeutics (NASDAQ:GPCR) on 2/28/2025 |
SKYE Skye Bioscience | $2.11
-10.3% | 2/28/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Outperform | | High | View details for William Blair rating of Skye Bioscience (NASDAQ:SKYE) on 2/28/2025 |
SKYE Skye Bioscience | $2.11
-22.7% | 2/28/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Outperform | | High | View details for William Blair rating of Skye Bioscience (NASDAQ:SKYE) on 2/28/2025 |
CRBP Corbus Pharmaceuticals | $5.83
-2.1% | 2/28/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Outperform | | Low | View details for William Blair rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 2/28/2025 |
ALT Altimmune | $5.92
-2.2% | 2/28/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Market Perform | | High | View details for William Blair rating of Altimmune (NASDAQ:ALT) on 2/28/2025 |
LZ LegalZoom.com | $9.34
+0.8% | 2/27/2025 | Reiterated by | William Blair | Analyst S. Sheldon | Market Perform | | High | View details for William Blair rating of LegalZoom.com (NASDAQ:LZ) on 2/27/2025 |
EVTC EVERTEC | $37.57
+0.1% | 2/27/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of EVERTEC (NYSE:EVTC) on 2/27/2025 |
CBZ CBIZ | $73.80
-0.3% | 2/27/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of CBIZ (NYSE:CBZ) on 2/27/2025 |
CERT Certara | $10.71
-0.7% | 2/27/2025 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Certara (NASDAQ:CERT) on 2/27/2025 |
USPH U.S. Physical Therapy | $74.28
+0.8% | 2/27/2025 | Reiterated by | William Blair | - | Market Perform | | Medium | View details for William Blair rating of U.S. Physical Therapy (NYSE:USPH) on 2/27/2025 |
CAVA CAVA Group | $90.46
+0.1% | 2/26/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of CAVA Group (NYSE:CAVA) on 2/26/2025 |
HURN Huron Consulting Group | $144.79
+1.3% | 2/26/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Huron Consulting Group (NASDAQ:HURN) on 2/26/2025 |
ALNY Alnylam Pharmaceuticals | $289.39
-0.5% | 2/26/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/26/2025 |
ONTF ON24 | $5.63
+0.3% | 2/26/2025 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of ON24 (NYSE:ONTF) on 2/26/2025 |
ZETA Zeta Global | $15.57
-0.6% | 2/26/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Zeta Global (NYSE:ZETA) on 2/26/2025 |
HSTM HealthStream | $32.16
+0.4% | 2/25/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of HealthStream (NASDAQ:HSTM) on 2/25/2025 |
NKTR Nektar Therapeutics | $0.82
-4.4% | 2/25/2025 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Nektar Therapeutics (NASDAQ:NKTR) on 2/25/2025 |
TEM Tempus AI | $58.86
-0.2% | 2/25/2025 | Reiterated by | William Blair | Analyst A. Brackmann | Market Perform | | Medium | View details for William Blair rating of Tempus AI (NASDAQ:TEM) on 2/25/2025 |
BAND Bandwidth | $15.43
+1.1% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Bandwidth (NASDAQ:BAND) on 2/21/2025 |
FIVN Five9 | $31.36
+1.6% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Five9 (NASDAQ:FIVN) on 2/21/2025 |
SPRY ARS Pharmaceuticals | $12.84
-0.4% | 2/21/2025 | Reiterated by | William Blair | Analyst L. Hanbury-Brown | Outperform | | Low | View details for William Blair rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/21/2025 |
DVAX Dynavax Technologies | $13.86
+0.1% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Dynavax Technologies (NASDAQ:DVAX) on 2/21/2025 |
VERV Verve Therapeutics | $5.48
-5.2% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Verve Therapeutics (NASDAQ:VERV) on 2/21/2025 |
LDOS Leidos | $135.40
-0.3% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | High | View details for William Blair rating of Leidos (NYSE:LDOS) on 2/21/2025 |
Wall Street's Algorithms Are Making One-Sided Trades (Here's How to Spot Them) (Ad) Have you noticed how certain stocks move in unnaturally straight lines lately? I watched CAKE last week steadily decline day after day in an almost perfect downward channel. Click here to discover how the Genesis Cog works in falling markets |
GD General Dynamics | $265.75
0.0% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | Low | View details for William Blair rating of General Dynamics (NYSE:GD) on 2/21/2025 |
CACI CACI International | $364.57
-1.9% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | High | View details for William Blair rating of CACI International (NYSE:CACI) on 2/21/2025 |
BAH Booz Allen Hamilton | $103.73
-1.4% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | Medium | View details for William Blair rating of Booz Allen Hamilton (NYSE:BAH) on 2/21/2025 |
KVYO Klaviyo | $34.22
+0.8% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Klaviyo (NYSE:KVYO) on 2/20/2025 |
CVNA Carvana | $217.11
+1.6% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Carvana (NYSE:CVNA) on 2/20/2025 |
CAKE Cheesecake Factory | $51.40
+0.4% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Cheesecake Factory (NASDAQ:CAKE) on 2/20/2025 |
RELY Remitly Global | $20.90
-0.3% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Remitly Global (NASDAQ:RELY) on 2/20/2025 |
EXAS Exact Sciences | $46.18
-1.9% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 2/20/2025 |
CSGP CoStar Group | $79.85
-0.4% | 2/19/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of CoStar Group (NASDAQ:CSGP) on 2/19/2025 |
FIS Fidelity National Information Services | $74.23
-0.1% | 2/18/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Fidelity National Information Services (NYSE:FIS) on 2/18/2025 |
JKHY Jack Henry & Associates | $171.90
-0.5% | 2/18/2025 | Reiterated by | William Blair | Analyst C. Kennedy | Outperform | | Medium | View details for William Blair rating of Jack Henry & Associates (NASDAQ:JKHY) on 2/18/2025 |
AXSM Axsome Therapeutics | $123.64
-4.3% | 2/18/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/18/2025 |
PSN Parsons | $61.63
+1.9% | 2/18/2025 | Upgraded by | William Blair | Analyst L. Dipalma | Market Perform -> Outperform | | High | View details for William Blair rating of Parsons (NYSE:PSN) on 2/18/2025 |
TWLO Twilio | $108.04
+1.7% | 2/14/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Twilio (NYSE:TWLO) on 2/14/2025 |
CWST Casella Waste Systems | $112.54
+1.6% | 2/14/2025 | Reiterated by | William Blair | Analyst T. Romeo | Outperform | | High | View details for William Blair rating of Casella Waste Systems (NASDAQ:CWST) on 2/14/2025 |
MCO Moody's | $473.27
+0.9% | 2/14/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Moody’s (NYSE:MCO) on 2/14/2025 |
RSG Republic Services | $237.26
+0.5% | 2/14/2025 | Reiterated by | William Blair | Analyst T. Romeo | Outperform | | Medium | View details for William Blair rating of Republic Services (NYSE:RSG) on 2/14/2025 |
TRU TransUnion | $88.01
+0.3% | 2/14/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of TransUnion (NYSE:TRU) on 2/14/2025 |
HUBS HubSpot | $632.72
+0.9% | 2/13/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of HubSpot (NYSE:HUBS) on 2/13/2025 |
MANH Manhattan Associates | $177.94
0.0% | 2/13/2025 | Upgraded by | William Blair | Analyst Dylan Becker | Market Perform -> Outperform | | Low | View details for William Blair rating of Manhattan Associates (NASDAQ:MANH) on 2/13/2025 |
TEM Tempus AI | $58.86
-0.2% | 2/12/2025 | Downgraded by | William Blair | Analyst Andrew Brackmann | Outperform -> Market Perform | | High | View details for William Blair rating of Tempus AI (NASDAQ:TEM) on 2/12/2025 |
STAA STAAR Surgical | $17.89
+0.7% | 2/12/2025 | Downgraded by | William Blair | Analyst Margaret Kaczor | Outperform -> Market Perform | | High | View details for William Blair rating of STAAR Surgical (NASDAQ:STAA) on 2/12/2025 |
ACLS Axcelis Technologies | $57.08
-0.8% | 2/12/2025 | Downgraded by | William Blair | Analyst Jed Dorsheimer | Outperform -> Market Perform | | Low | View details for William Blair rating of Axcelis Technologies (NASDAQ:ACLS) on 2/12/2025 |
VSAT Viasat | $11.68
+4.3% | 2/7/2025 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Viasat (NASDAQ:VSAT) on 2/7/2025 |
EHC Encompass Health | $100.61
+0.7% | 2/7/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Encompass Health (NYSE:EHC) on 2/7/2025 |
NBIX Neurocrine Biosciences | $115.15
-0.4% | 2/7/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/7/2025 |
EFX Equifax | $245.00
-0.1% | 2/7/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Equifax (NYSE:EFX) on 2/7/2025 |
RBRK Rubrik | $74.88
+1.9% | 2/7/2025 | Initiated by | William Blair | Analyst Jason Ader | Market Perform | | Medium | View details for William Blair rating of Rubrik (NYSE:RBRK) on 2/7/2025 |
CXM Sprinklr | $9.06
+0.8% | 2/7/2025 | Downgraded by | William Blair | Analyst A. Bhatia | Outperform -> Market Perform | | Low | View details for William Blair rating of Sprinklr (NYSE:CXM) on 2/7/2025 |
WEX WEX | $156.64
-0.6% | 2/6/2025 | Reiterated by | William Blair | Analyst Andrew Jeffrey | Outperform -> Market Perform | | Low | View details for William Blair rating of WEX (NYSE:WEX) on 2/6/2025 |
HOLX Hologic | $61.81
-0.1% | 2/6/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 2/6/2025 |
MRSN Mersana Therapeutics | $0.42
-4.7% | 2/6/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Outperform | | High | View details for William Blair rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/6/2025 |
MRVL Marvell Technology | $72.56
-0.3% | 2/5/2025 | Upgraded by | William Blair | Analyst S. Naji | Strong-Buy | | Low | View details for William Blair rating of Marvell Technology (NASDAQ:MRVL) on 2/5/2025 |
MA Mastercard | $543.96
+0.1% | 1/31/2025 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | High | View details for William Blair rating of Mastercard (NYSE:MA) on 1/31/2025 |
V Visa | $342.53
-0.4% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Visa (NYSE:V) on 1/31/2025 |
WM Waste Management | $226.79
+0.2% | 1/31/2025 | Reiterated by | William Blair | Analyst T. Romeo | Outperform | | Medium | View details for William Blair rating of Waste Management (NYSE:WM) on 1/31/2025 |
VRTX Vertex Pharmaceuticals | $509.33
-0.5% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/31/2025 |
APPF AppFolio | $222.32
+0.8% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of AppFolio (NASDAQ:APPF) on 1/31/2025 |
TEAM Atlassian | $236.07
+0.6% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Atlassian (NASDAQ:TEAM) on 1/31/2025 |
CRGX CARGO Therapeutics | $4.15
-1.2% | 1/30/2025 | Downgraded by | William Blair | Analyst S. Corwin | Outperform -> Market Perform | | N/A | View details for William Blair rating of CARGO Therapeutics (NASDAQ:CRGX) on 1/30/2025 |
CVLT Commvault Systems | $171.79
+1.5% | 1/30/2025 | Upgraded by | William Blair | Analyst Jason Ader | Market Perform -> Outperform | | High | View details for William Blair rating of Commvault Systems (NASDAQ:CVLT) on 1/30/2025 |
FNA Paragon 28 | $13.02
+0.1% | 1/29/2025 | Downgraded by | William Blair | Analyst Brandon Vazquez | Outperform -> Market Perform | | High | View details for William Blair rating of Paragon 28 (NYSE:FNA) on 1/29/2025 |
AXP American Express | $277.64
-0.1% | 1/27/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of American Express (NYSE:AXP) on 1/27/2025 |
SAUHY Straumann | $12.75
-0.4% | 1/24/2025 | Upgraded by | William Blair | Analyst B. Vazquez | Strong-Buy | | Medium | View details for William Blair rating of Straumann (OTCMKTS:SAUHY) on 1/24/2025 |
TWLO Twilio | $108.04
+1.7% | 1/24/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Twilio (NYSE:TWLO) on 1/24/2025 |
AXSM Axsome Therapeutics | $123.64
-4.3% | 1/24/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/24/2025 |
SOFI SoFi Technologies | $13.68
-0.3% | 1/24/2025 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | Low | View details for William Blair rating of SoFi Technologies (NASDAQ:SOFI) on 1/24/2025 |
GEV GE Vernova | $335.40
-2.4% | 1/23/2025 | Reiterated by | William Blair | Analyst J. Dorsheimer | Outperform | | High | View details for William Blair rating of GE Vernova (NYSE:GEV) on 1/23/2025 |
PSN Parsons | $61.63
+1.9% | 1/23/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | High | View details for William Blair rating of Parsons (NYSE:PSN) on 1/23/2025 |
CRL Charles River Laboratories International | $165.61
-0.8% | 1/22/2025 | Downgraded by | William Blair | Analyst Max Smock | Outperform -> Market Perform | | Low | View details for William Blair rating of Charles River Laboratories International (NYSE:CRL) on 1/22/2025 |
Trump’s Great Society (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
STRL Sterling Infrastructure | $130.67
-2.5% | 1/17/2025 | Initiated by | William Blair | Analyst Louie DiPalma | Outperform | | High | View details for William Blair rating of Sterling Infrastructure (NASDAQ:STRL) on 1/17/2025 |
DNLI Denali Therapeutics | $14.52
-1.6% | 1/15/2025 | Reiterated by | William Blair | Analyst S. Schram | Outperform | | High | View details for William Blair rating of Denali Therapeutics (NASDAQ:DNLI) on 1/15/2025 |
NMRA Neumora Therapeutics | $1.17
-2.9% | 1/15/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Neumora Therapeutics (NASDAQ:NMRA) on 1/15/2025 |
AFRM Affirm | $52.21
-0.6% | 1/15/2025 | Initiated by | William Blair | Analyst Andrew Jeffrey | Outperform | | High | View details for William Blair rating of Affirm (NASDAQ:AFRM) on 1/15/2025 |
SOFI SoFi Technologies | $13.68
-0.3% | 1/15/2025 | Initiated by | William Blair | Analyst Andrew Jeffrey | Outperform | | High | View details for William Blair rating of SoFi Technologies (NASDAQ:SOFI) on 1/15/2025 |
CRL Charles River Laboratories International | $165.61
-0.8% | 1/14/2025 | Reiterated by | William Blair | Analyst Max Smock | Outperform -> Outperform | | Low | View details for William Blair rating of Charles River Laboratories International (NYSE:CRL) on 1/14/2025 |
ICLR ICON Public | $185.16
+0.4% | 1/14/2025 | Reiterated by | William Blair | Analyst Max Smock | Outperform -> Outperform | | High | View details for William Blair rating of ICON Public (NASDAQ:ICLR) on 1/14/2025 |
CVRX CVRx | $12.82
+0.5% | 1/14/2025 | Upgraded by | William Blair | Analyst Margaret Kaczor | Market Perform -> Outperform | | High | View details for William Blair rating of CVRx (NASDAQ:CVRX) on 1/14/2025 |
BIIB Biogen | $141.08
-0.4% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 1/13/2025 |
EXAS Exact Sciences | $46.18
-1.9% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 1/13/2025 |
HOLX Hologic | $61.81
-0.1% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 1/13/2025 |
VRTX Vertex Pharmaceuticals | $509.33
-0.5% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/13/2025 |
ENFN Enfusion | $11.18
+0.3% | 1/13/2025 | Reiterated by | William Blair | Analyst Bhavan Suri | Outperform -> Market Perform | | High | View details for William Blair rating of Enfusion (NYSE:ENFN) on 1/13/2025 |
JANX Janux Therapeutics | $30.88
-2.7% | 1/10/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 1/10/2025 |
ACCD Accolade | $7.01
+0.1% | 1/8/2025 | Downgraded by | William Blair | Analyst R. Daniels | Strong-Buy -> Hold | | Low | View details for William Blair rating of Accolade (NASDAQ:ACCD) on 1/8/2025 |
CBOE Cboe Global Markets | $214.69
+0.8% | 1/9/2025 | Initiated by | William Blair | Analyst J. Schmitt | Market Perform | | Low | View details for William Blair rating of Cboe Global Markets (NASDAQ:CBOE) on 1/9/2025 |
KRUS Kura Sushi USA | $61.52
-0.4% | 1/8/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Kura Sushi USA (NASDAQ:KRUS) on 1/8/2025 |
SLP Simulations Plus | $25.66
+0.5% | 1/8/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 1/8/2025 |
NARI Inari Medical | $79.97
| 1/7/2025 | Reiterated by | William Blair | Analyst M. Kaczor | Outperform -> Market Perform | | Low | View details for William Blair rating of Inari Medical (NASDAQ:NARI) on 1/7/2025 |
CSGP CoStar Group | $79.85
-0.4% | 1/6/2025 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of CoStar Group (NASDAQ:CSGP) on 1/6/2025 |
TTAN ServiceTitan | $95.48
+0.5% | 1/6/2025 | Initiated by | William Blair | Analyst D. Becker | Outperform | | N/A | View details for William Blair rating of ServiceTitan (NASDAQ:TTAN) on 1/6/2025 |
DNLI Denali Therapeutics | $14.52
-1.6% | 1/3/2025 | Initiated by | William Blair | Analyst S. Schram | Outperform | | N/A | View details for William Blair rating of Denali Therapeutics (NASDAQ:DNLI) on 1/3/2025 |
ELEV Elevation Oncology | $0.28
-4.2% | 1/3/2025 | Initiated by | William Blair | Analyst A. Hsieh | Outperform | | N/A | View details for William Blair rating of Elevation Oncology (NASDAQ:ELEV) on 1/3/2025 |
AYI Acuity Brands | $278.04
+1.0% | 1/2/2025 | Upgraded by | William Blair | Analyst R. Merkel | Market Perform -> Outperform | | N/A | View details for William Blair rating of Acuity Brands (NYSE:AYI) on 1/2/2025 |
KRT Karat Packaging | $28.44
-0.2% | 1/2/2025 | Downgraded by | William Blair | Analyst R. Merkel | Outperform -> Market Perform | | N/A | View details for William Blair rating of Karat Packaging (NASDAQ:KRT) on 1/2/2025 |
HLMN Hillman Solutions | $8.98
-0.7% | 1/2/2025 | Downgraded by | William Blair | Analyst R. Merkel | Outperform -> Market Perform | | N/A | View details for William Blair rating of Hillman Solutions (NASDAQ:HLMN) on 1/2/2025 |
APLT Applied Therapeutics | $0.53
-4.9% | 12/23/2024 | Downgraded by | William Blair | Analyst S. Corwin | Outperform -> Market Perform | | N/A | View details for William Blair rating of Applied Therapeutics (NASDAQ:APLT) on 12/23/2024 |
IONS Ionis Pharmaceuticals | $33.00
-1.3% | 12/20/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 12/20/2024 |
ZETA Zeta Global | $15.57
-0.6% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Zeta Global (NYSE:ZETA) on 12/19/2024 |
SMWB Similarweb | $9.21
+0.1% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Similarweb (NYSE:SMWB) on 12/19/2024 |
KVYO Klaviyo | $34.22
+0.8% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Klaviyo (NYSE:KVYO) on 12/19/2024 |
BRZE Braze | $38.59
+1.2% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Braze (NASDAQ:BRZE) on 12/19/2024 |
MNDY monday.com | $279.43
+1.1% | 12/18/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of monday.com (NASDAQ:MNDY) on 12/18/2024 |
PLTR Palantir Technologies | $96.27
-0.5% | 12/18/2024 | Reiterated by | William Blair | - | Underperform | | N/A | View details for William Blair rating of Palantir Technologies (NASDAQ:PLTR) on 12/18/2024 |
EVTC EVERTEC | $37.57
+0.1% | 12/18/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of EVERTEC (NYSE:EVTC) on 12/18/2024 |
BROS Dutch Bros | $69.32
-1.6% | 12/17/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Dutch Bros (NYSE:BROS) on 12/17/2024 |
NBIX Neurocrine Biosciences | $115.15
-0.4% | 12/16/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
INCY Incyte | $62.86
+0.1% | 12/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Incyte (NASDAQ:INCY) on 12/13/2024 |
KROS Keros Therapeutics | $11.25
-1.7% | 12/12/2024 | Downgraded by | William Blair | Analyst M. Phipps | Outperform -> Market Perform | | N/A | View details for William Blair rating of Keros Therapeutics (NASDAQ:KROS) on 12/12/2024 |
GEV GE Vernova | $335.40
-2.4% | 12/11/2024 | Reiterated by | William Blair | Analyst J. Dorsheimer | Outperform | | N/A | View details for William Blair rating of GE Vernova (NYSE:GEV) on 12/11/2024 |
FA First Advantage | $14.00
| 12/11/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of First Advantage (NYSE:FA) on 12/11/2024 |
IQV IQVIA | $185.95
-0.1% | 12/11/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of IQVIA (NYSE:IQV) on 12/11/2024 |
PLAY Dave & Buster's Entertainment | $20.63
-2.5% | 12/11/2024 | Reiterated by | William Blair | Analyst S. Zackfia | Outperform -> Market Perform | | N/A | View details for William Blair rating of Dave & Buster’s Entertainment (NASDAQ:PLAY) on 12/11/2024 |
LULU Lululemon Athletica | $338.47
+1.0% | 12/6/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Lululemon Athletica (NASDAQ:LULU) on 12/6/2024 |
SPNS Sapiens International | $27.34
-0.4% | 12/6/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Sapiens International (NASDAQ:SPNS) on 12/6/2024 |
CCRN Cross Country Healthcare | $14.97
-0.2% | 12/4/2024 | Downgraded by | William Blair | Analyst T. Romeo | Strong-Buy -> Hold | | N/A | View details for William Blair rating of Cross Country Healthcare (NASDAQ:CCRN) on 12/4/2024 |
NCNO nCino | $29.17
+0.7% | 12/5/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of nCino (NASDAQ:NCNO) on 12/5/2024 |
AVAV AeroVironment | $129.60
+0.7% | 12/5/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of AeroVironment (NASDAQ:AVAV) on 12/5/2024 |
SYM Symbotic | $23.34
-0.7% | 12/5/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Symbotic (NASDAQ:SYM) on 12/5/2024 |
APG APi Group | $38.10
-0.8% | 12/5/2024 | Reiterated by | William Blair | Analyst T. Mulrooney | Outperform | | N/A | View details for William Blair rating of APi Group (NYSE:APG) on 12/5/2024 |
Trump’s Great Society (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
PLTR Palantir Technologies | $96.27
-0.5% | 12/4/2024 | Reiterated by | William Blair | - | Underperform | | N/A | View details for William Blair rating of Palantir Technologies (NASDAQ:PLTR) on 12/4/2024 |
VIGL Vigil Neuroscience | $1.86
-2.2% | 12/4/2024 | Initiated by | William Blair | Analyst S. Schram | Outperform | | N/A | View details for William Blair rating of Vigil Neuroscience (NASDAQ:VIGL) on 12/4/2024 |
JANX Janux Therapeutics | $30.88
-2.7% | 12/3/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
APLT Applied Therapeutics | $0.53
-4.9% | 11/28/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | N/A | View details for William Blair rating of Applied Therapeutics (NASDAQ:APLT) on 11/28/2024 |
FIVE Five Below | $79.17
-0.1% | 12/2/2024 | Reiterated by | William Blair | Analyst P. Blee | Market Perform | | N/A | View details for William Blair rating of Five Below (NASDAQ:FIVE) on 12/2/2024 |
LESL Leslie's | $0.85
+3.4% | 11/26/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Leslie’s (NASDAQ:LESL) on 11/26/2024 |
RBC RBC Bearings | $336.38
+0.4% | 11/26/2024 | Reiterated by | William Blair | Analyst R. Sparenblek | Outperform | | N/A | View details for William Blair rating of RBC Bearings (NYSE:RBC) on 11/26/2024 |
CRGX CARGO Therapeutics | $4.15
-1.2% | 11/26/2024 | Initiated by | William Blair | Analyst S. Corwin | Outperform | | N/A | View details for William Blair rating of CARGO Therapeutics (NASDAQ:CRGX) on 11/26/2024 |
MA Mastercard | $543.96
+0.1% | 11/25/2024 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | N/A | View details for William Blair rating of Mastercard (NYSE:MA) on 11/25/2024 |
NDAQ Nasdaq | $77.61
+0.3% | 11/25/2024 | Initiated by | William Blair | Analyst J. Schmitt | Outperform | | N/A | View details for William Blair rating of Nasdaq (NASDAQ:NDAQ) on 11/25/2024 |
TLX Telix Pharmaceuticals Limited American Depositary Shares | $18.31
+0.4% | 11/19/2024 | Upgraded by | William Blair | Analyst A. Hsieh | Strong-Buy | | N/A | View details for William Blair rating of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) on 11/19/2024 |
EXAS Exact Sciences | $46.18
-1.9% | 11/21/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 11/21/2024 |
ULTA Ulta Beauty | $369.54
+0.9% | 11/21/2024 | Downgraded by | William Blair | Analyst D. Carden | Outperform -> Market Perform | | N/A | View details for William Blair rating of Ulta Beauty (NASDAQ:ULTA) on 11/21/2024 |
PYXS Pyxis Oncology | $1.17
-2.5% | 11/21/2024 | Downgraded by | William Blair | Analyst A. Hsieh | Outperform -> Market Perform | | N/A | View details for William Blair rating of Pyxis Oncology (NASDAQ:PYXS) on 11/21/2024 |
AIOT Powerfleet | $6.09
-1.7% | 11/21/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Powerfleet (NASDAQ:AIOT) on 11/21/2024 |
QDEL QuidelOrtho | $36.06
-1.2% | 11/20/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of QuidelOrtho (NASDAQ:QDEL) on 11/20/2024 |
VKTX Viking Therapeutics | $28.61
-2.3% | 11/20/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Viking Therapeutics (NASDAQ:VKTX) on 11/20/2024 |
SLN Silence Therapeutics | $3.38
-3.2% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Silence Therapeutics (NASDAQ:SLN) on 11/19/2024 |
NGNE Neurogene | $14.05
+0.6% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Neurogene (NASDAQ:NGNE) on 11/19/2024 |
LRMR Larimar Therapeutics | $2.27
-0.7% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Larimar Therapeutics (NASDAQ:LRMR) on 11/19/2024 |
ALNY Alnylam Pharmaceuticals | $289.39
-0.5% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/19/2024 |
CABA Cabaletta Bio | $1.68
-2.6% | 11/18/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Cabaletta Bio (NASDAQ:CABA) on 11/18/2024 |
NTLA Intellia Therapeutics | $8.83
-5.1% | 11/18/2024 | Reiterated by | William Blair | - | Neutral | $14.00 | N/A | View details for William Blair rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
INGM Ingram Micro | $20.29
+1.8% | 11/18/2024 | Initiated by | William Blair | Analyst M. Nolan | Outperform | | N/A | View details for William Blair rating of Ingram Micro (NYSE:INGM) on 11/18/2024 |
XYZ Block | $62.53
-0.1% | 11/15/2024 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | N/A | View details for William Blair rating of Block (NYSE:XYZ) on 11/15/2024 |
REKR Rekor Systems | $1.11
-3.9% | 11/15/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Rekor Systems (NASDAQ:REKR) on 11/15/2024 |
BV BrightView | $13.29
+0.2% | 11/15/2024 | Upgraded by | William Blair | Analyst T. Mulrooney | Market Perform -> Outperform | | N/A | View details for William Blair rating of BrightView (NYSE:BV) on 11/15/2024 |
ALLO Allogene Therapeutics | $1.63
-3.0% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Allogene Therapeutics (NASDAQ:ALLO) on 11/14/2024 |
JANX Janux Therapeutics | $30.88
-2.7% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 11/14/2024 |
OPRX OptimizeRx | $9.33
+3.7% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of OptimizeRx (NASDAQ:OPRX) on 11/14/2024 |
BOX BOX | $30.94
+0.4% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of BOX (NYSE:BOX) on 11/14/2024 |
PSTG Pure Storage | $52.98
+0.2% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Pure Storage (NYSE:PSTG) on 11/14/2024 |
XGN Exagen | $3.96
-2.2% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Exagen (NASDAQ:XGN) on 11/13/2024 |
FGEN FibroGen | $0.38
+3.3% | 11/13/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of FibroGen (NASDAQ:FGEN) on 11/13/2024 |
KZR Kezar Life Sciences | $5.64
-8.4% | 11/13/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Kezar Life Sciences (NASDAQ:KZR) on 11/13/2024 |
KRRO Korro Bio | $23.62
-1.7% | 11/13/2024 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | N/A | View details for William Blair rating of Korro Bio (NASDAQ:KRRO) on 11/13/2024 |
TPST Tempest Therapeutics | $0.82
-0.4% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Tempest Therapeutics (NASDAQ:TPST) on 11/13/2024 |
FA First Advantage | $14.00
| 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of First Advantage (NYSE:FA) on 11/13/2024 |
CAVA CAVA Group | $90.46
+0.1% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of CAVA Group (NYSE:CAVA) on 11/13/2024 |
AMGN Amgen | $311.40
-0.9% | 11/12/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Amgen (NASDAQ:AMGN) on 11/12/2024 |
FTRE Fortrea | $8.98
-4.5% | 11/8/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Fortrea (NASDAQ:FTRE) on 11/8/2024 |
MRVI Maravai LifeSciences | $2.36
+5.2% | 11/8/2024 | Reiterated by | William Blair | Analyst M. Larew | Outperform -> Market Perform | | N/A | View details for William Blair rating of Maravai LifeSciences (NASDAQ:MRVI) on 11/8/2024 |
AMN AMN Healthcare Services | $24.70
+0.8% | 11/8/2024 | Downgraded by | William Blair | Analyst T. Romeo | Outperform -> Market Perform | | N/A | View details for William Blair rating of AMN Healthcare Services (NYSE:AMN) on 11/8/2024 |
AGL agilon health | $4.53
+1.0% | 11/8/2024 | Downgraded by | William Blair | Analyst R. Daniels | Outperform -> Market Perform | | N/A | View details for William Blair rating of agilon health (NYSE:AGL) on 11/8/2024 |
JKHY Jack Henry & Associates | $171.90
-0.5% | 11/6/2024 | Downgraded by | William Blair | Analyst C. Kennedy | Strong-Buy -> Hold | | N/A | View details for William Blair rating of Jack Henry & Associates (NASDAQ:JKHY) on 11/6/2024 |
WRBY Warby Parker | $19.66
-2.8% | 11/7/2024 | Upgraded by | William Blair | Analyst D. Carden | Market Perform -> Outperform | | N/A | View details for William Blair rating of Warby Parker (NYSE:WRBY) on 11/7/2024 |
CDMO Avid Bioservices | $12.50
+0.1% | 11/7/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Avid Bioservices (NASDAQ:CDMO) on 11/7/2024 |
CLVT Clarivate | $4.19
+1.3% | 11/6/2024 | Downgraded by | William Blair | Analyst A. Nicholas | Outperform -> Market Perform | | N/A | View details for William Blair rating of Clarivate (NYSE:CLVT) on 11/6/2024 |
SLP Simulations Plus | $25.66
+0.5% | 11/6/2024 | Reiterated by | William Blair | Analyst M. Smock | Outperform | | N/A | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 11/6/2024 |
UPB Upstream Bio | $7.51
-2.5% | 11/5/2024 | Initiated by | William Blair | Analyst M. Phipps | Outperform | | High | View details for William Blair rating of Upstream Bio (NASDAQ:UPB) on 11/5/2024 |
CBLL CeriBell | $20.85
-1.0% | 11/5/2024 | Initiated by | William Blair | Analyst M. Kaczor | Outperform | | High | View details for William Blair rating of CeriBell (NASDAQ:CBLL) on 11/5/2024 |
MQ Marqeta | $4.53
+1.0% | 11/5/2024 | Downgraded by | William Blair | Analyst C. Kennedy | Outperform -> Market Perform | | High | View details for William Blair rating of Marqeta (NASDAQ:MQ) on 11/5/2024 |
ARGX argenx | $610.43
+0.4% | 11/1/2024 | Upgraded by | William Blair | Analyst M. Minter | Market Perform -> Outperform | | Medium | View details for William Blair rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
ALTR Altair Engineering | $111.82
+0.1% | 10/31/2024 | Reiterated by | William Blair | Analyst D. Becker | Outperform -> Market Perform | | High | View details for William Blair rating of Altair Engineering (NASDAQ:ALTR) on 10/31/2024 |
BMRN BioMarin Pharmaceutical | $71.75
-0.3% | 10/30/2024 | Downgraded by | William Blair | Analyst S. Corwin | Outperform -> Market Perform | | High | View details for William Blair rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/30/2024 |
PRM Cott | C$13.47
+2.0% | 10/24/2024 | Upgraded by | William Blair | Analyst J. Andersen | Strong-Buy | | N/A | View details for William Blair rating of Cott (TSE:PRM) on 10/24/2024 |
SLP Simulations Plus | $25.66
+0.5% | 10/24/2024 | Reiterated by | William Blair | Analyst M. Smock | Outperform | | High | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 10/24/2024 |
MEDP Medpace | $329.78
-0.2% | 10/22/2024 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Medpace (NASDAQ:MEDP) on 10/22/2024 |
BWIN The Baldwin Insurance Group | $46.74
+2.0% | 10/17/2024 | Upgraded by | William Blair | Analyst A. Klauber | Market Perform -> Outperform | | High | View details for William Blair rating of The Baldwin Insurance Group (NASDAQ:BWIN) on 10/17/2024 |
APLS Apellis Pharmaceuticals | $24.09
-0.7% | 10/16/2024 | Initiated by | William Blair | Analyst L. Hanbury-Brown | Outperform | | Low | View details for William Blair rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 10/16/2024 |
